Rapid antibody test
The rapid antibody test (Bioeasy COVID-19 Coronavirus IgG / IgM GICA
Rapid Test Kit ©) used for evaluation gives a qualitative IgG / IgM
result to reveal a current or past SARS-CoV-2 infection (20). This test
has been approved by the Ministry of Health for use in detecting
antibody formation in risk groups in the community, healthcare workers
and recovered patients. There are rapid antibody tests used for COVID-19
and produced by different companies. In head-to-head studies conducted
with these tests, Bioeasy kits have been reported to have 91-95%
sensitivity levels (ĸ: 0.8, p <0.001) (20). The rapid antibody
test gives results in as little as 30 minutes. The serum sample taken
for the test is dropped onto the cassette of the rapid test kit and the
presence of antibody is qualitatively shown in 15 minutes.